Medpage Today: Tricuspid Clip Might Work for More Patients Than Thought

Tricuspid transcatheter edge-to-edge repair (T-TEER) performed better than anticipated in patients expected to have only a modest benefit due to more complex anatomy, the TRILUMINATE trial showed.

After receiving the investigational TriClip device to hold the leaflets together, most patients enrolled in the single-arm portion of the trial as a result of their complex anatomies -- presumed to preclude a reduction in tricuspid regurgitation (TR) to moderate or less -- actually achieved that grade of regurgitation.

In a separate analysis of the initial 350 randomized patients diving deeper into the quality of life findings, Suzanne Arnold, MD, MHA, of Saint Luke's Mid America Heart Institute and the University of Missouri-Kansas City, reported a number needed to treat of 3.5 for one additional patient to be alive and well at 12 months.

"Exploratory analyses suggested that much of the health status benefit of T-TEER could be explained by TR reduction and that improvement in health status after T-TEER was strongly correlated with reduced 1-year mortality and heart failure hospitalization," her group wrote in a paper simultaneously released in the Journal of the American College of Cardiology.

Read the full Medpage Today article: Tricuspid Clip Might Work for More Patients Than Thought

Related Content

Oct. 27, 2023

TCDMD: TRILUMINATE Deep Dive Clarifies 'Meaningful' Quality of Life Gains with Tricuspid TEER

Dr. Suzanne Arnold presented findings from the pivotal TRILUMINATE trial.
Sep. 21, 2023

Healio: Minimally Symptomatic Patients Likely to Survive with Good Health Status After TAVR

Dr. Chetan Huded and colleagues found patients with minimal symptoms who underwent TAVR were more likely to survive with good health status at one year than more symptomatic patients.
Sep. 21, 2023

Medpage Today: Reassuring Registry Data on Going Into TAVR Sans Symptoms

Transcatheter aortic valve replacement (TAVR) got some preliminary affirmation for asymptomatic or minimally symptomatic severe aortic stenosis in a retrospective registry study.